Protein tyrosine phosphatases (PTPs), working with protein tyrosine kinases (PTKs), control the phosphorylation state of many proteins in the signal transduction pathways. HePTP is a tyrosine phosphatase expressed in hematopoietic cells and regulates the MAP kinases Erk and p38. It has been found that HePTP is often dysregualted in the preleukemic disorder myelodysplastic syndrome, as well as in acute myelogeneous leukemia. Small molecule inhibitors of HePTP will be useful as molecular probes for studying the mechanism of signal transduction and MAP kinase regulation, and may have therapeutic potential for the treatment of hematopoietic malignancies. In this assay, activity of HePTP is evaluated in the absence of DTT normally present as part of the buffer during SAR studies (AID 1077). The catalytic reaction is initiated with substrate addition. Enzyme activity and its inhibition by test compounds is measured in a kinetic assay based on hydrolysis of 3-O-methylfluorescein phosphate (OMFP) resulting in a fluorescence increase due to 3-O-methylfluorescein release. HePTP assay materials: HePTP assay materials: 1)HePTP protein was provided by Dr. Mustelin (Sanford-Burnham Medical Research Institute, San Diego, CA). 2)Assay Buffer: 50 mM Bis-Tris, pH 6.0, 375 mM NaCl, 0 mM DTT, 0.0125% Tween 20. 3) Upon pre-incubation for 10 min. in the presence of 25 mM DTT, 20 uM HePTP enzyme stock was aliquoted and flash-frozen. HePTP working solution at 3 nM in the assay buffer without DTT was prepared using this pre-incubated stock. 4) OMFP working solution: 600 uM OMFP in the assay buffer HePTP dose-response assay protocol: 1) Using Thermo Scientific MultiDrop Combi dispense 10 ul of OMFP working solution into all columns of black small-volume Greiner plates (784076) 2) Using Thermo Scientific MultiDrop Combi dispense 10 uL of assay buffer in columns 1-2. 3) Using LabCyte Echo 550 add 0.2 uL of serially diluted compounds to columns 3-22 and DMSO to columns 1-2 and 23-24. Final concentration of DMSO was 1 % 4) Using Thermo Scientific MultiDrop Combi dispense 10 of HePTP working solution to wells in columns 3 through 24. 5) Incubate lidded plate for 1 hour at room temp. 6) Read plate on M5 plate reader in fluorescence mode (ex: 480nm; 3m: 520nm; dichroic mirror is 515 nm) 7)Data analysis and curve fitting was performed with CBIS software (ChemInnovations, Inc) by non-linear regression using 4 parameter binding model.
bao:BAO_0000541 "1077" ; # "is counter assay of" -> "1077"
bao:BAO_0001077 "521_1" ; # "is alternate confirmatory assay of" -> "521_1"
bao:BAO_0000812 "2085" ; # "has summary assay" -> "2085"
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0001078 bao:BAO_0001096 ; # "has orthogonal assay technology" -> "orthogonal assay technology"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000205 bao:BAO_0000224 ; # "has assay format" -> "protein format"
bao:BAO_0000205 bao:BAO_0000357 ; # "has assay format" -> "single protein format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000287 ; # "has participant" -> "hydrolase" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 "hydrolase activity assay" ; # "is bioassay type of" -> "hydrolase activity assay"
bao:BAO_0000212 bao:BAO_0000124 ; # "has assay method" -> "enzyme activity measurement method"
bao:BAO_0000212 bao:BAO_0000139 ; # "has assay method" -> "direct enzyme activity measurement method"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> bao:BAO_0000484 ; # "has assay design method" -> "enzyme inhibition"
bao:BAO_0000207 bao:BAO_0000363 ; # "has detection method" -> "fluorescence intensity"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"To discover of chemical inhibitors of HePTP, a leukemia target.\"" ; # "screening campaign name" -> ""To discover of chemical inhibitors of HePTP, a leukemia target.""
bao:BAO_0002853 "MOA HePTP Fluorescent secondary assay for identification of redox-state modulating compounds" ; # "has assay title" -> "MOA HePTP Fluorescent secondary assay for identification of redox-state modulating compounds"
bao:BAO_0002867 bao:BAO_0000515 ; # "has assay footprint" -> "384 well plate"
bao:BAO_0000109 "25 degree celsius" ; # "has temperature value" -> "25 degree celsius"
bao:BAO_0002833 "1 hour" ; # "has incubation time value" -> "1 hour"
bao:BA0_0090012 bao:BAO_0000118 ; # "has participant" -> "DMSO"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Tomas Mustelin" ; # "material entity assay provider" -> "Tomas Mustelin" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BA0_0090012 bao:BAO_0000694 ; # "has participant" -> "Tris" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35225> ; # "has role" -> "buffer"
bao:BA0_0090012 bao:BAO_0001038 ; # "has participant" -> "Tween 20" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_27780> ; # "has role" -> "detergent"
bao:BA0_0090012 "O-methylfluorescein phosphate" ; # "has participant" -> "O-methylfluorescein phosphate" || bao:BAO_0003102 bao:BAO_00020143 ; # "has role" -> "substrate"
bao:BA0_0090012 "Tyrosine-protein phosphatase non-receptor type 7 isoform 2" ; # "has participant" -> "Tyrosine-protein phosphatase non-receptor type 7 isoform 2"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "5778" ; # "gene ID" -> "5778"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P35236-2" ; # "uniprot ID" -> "P35236-2"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "5778" ; # "construct gene ID" -> "5778"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000822 ; # "has participant" -> "3-O-methyl-fluorescein"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000706 ; # "uses detection instrument" -> "SpectraMax M5 Multi-Mode Microplate Reader"
bao:BAO_0000737 bao:BAO_0000969 ; # "has manufacturer" -> "Molecular Devices" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "480 nanometer" ; # "has excitation wavelength value" -> "480 nanometer"
bao:BAO_0002918 "520 nanometer" ; # "has emission wavelength value" -> "520 nanometer"
bao:BAO_0000208 bao:BAO_0000190 ; # "has endpoint" -> "IC50"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
bao:BAO_0002845 "3" ; # "has repetition point-number" -> "3"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "kunie-2" ; # "Annotated by" -> "kunie-2"
